Latest USPTO News

Latest USPTO News

Thu, 14 Feb 2019 11:00:00 GMT

In-house sources at Peloton Technology and elsewhere explain that big data analysis tools could be increasingly used for analyses surrounding IP litigation as the technology becomes more reliable…

Mon, 11 Feb 2019 17:45:00 GMT

Part two of Patent Strategy’s survey of more than 60 in-house lawyers shows that most businesses believe artificial intelligence will be used for invention discovery, but that patenting those…

Thu, 07 Feb 2019 09:15:00 GMT

Patent Strategy’s landmark survey of more than 60 in-house lawyers shows that most businesses are still unsure about what can be patent protected and how best to apply for protection in the field of A…

Thu, 31 Jan 2019 12:30:00 GMT

In-house counsel explain that the convergence of technologies across different industries has brought new players and tech areas into these sectors and made analysing industry activity more difficult…

Mon, 28 Jan 2019 10:15:00 GMT

Sources at biotech companies and NPOs explain how the future enforceability of US cannabis patents in federal courts rests on whether UCANN v Pure Hemp is thrown out or not…

Wed, 23 Jan 2019 13:00:00 GMT

Counsel at Steep Hill Labs, Phylos Bioscience, Medicinal Genomics and the Open Cannabis Project explain how cannabinoid innovation could be blocked by overly broad or weak patents at the USPTO, and wh…

Tue, 22 Jan 2019 22:00:00 GMT

Managing IP invites its in-house counsel readers to take its survey on patenting AI, patenting AI-invented innovations and how AI could streamline the patenting process. Help inform the industry and, …

Wed, 16 Jan 2019 05:00:00 GMT

Counsel at the ZF Group, Philips, Siemens and elsewhere explain how the surge of domestic patents filings in China is making freedom-to-operate searches more difficult, and what they’re doing about th…

Tue, 15 Jan 2019 00:30:00 GMT

Lawyers from IBM and other artificial intelligence-focused businesses have welcomed the EPO’s new guidelines, but say kinks in the examination approach to the technology in Europe and elsewhere need t…

Wed, 09 Jan 2019 21:00:00 GMT

In-house counsel at Philips, Biotronik and elsewhere explain how their growing number of tech partnerships is affecting medical device patent negotiations, and how the surge of new players into the ma…

Have a Question? Get Free Consultation.